Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Dividends payables (2011 - 2025)

Updated

Sinovac Biotech (SVA) reported Dividends payables of $657.86 million for Q4 2025, up 208.9% from $212.96 million a year earlier.

Analysis

Sinovac Biotech (SVA) Dividends payables (2011 - 2025) Analysis & Trends

Dating back to Q4 2011, Sinovac Biotech's Dividends payables record includes 6 quarters.

  • Dividends payables has a five-year compound annual growth rate of 126.1% (FY2020 to FY2025).
  • By year, Dividends payables came in at $212.96 million in FY2024 and $118.89 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 2.13 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 2.45 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn - 657.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 657.86 Mn
Dec 31, 2024 212.96 Mn
Dec 31, 2022 118.89 Mn
Dec 31, 2020 11.14 Mn
Dec 31, 2019 5.13 Mn
Dec 31, 2011 795,106.00
API Access

Sinovac Biotech Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=SVA&period=max&api_key=YOUR_API_KEY